BioSpace News Archive

Report published by Trellis Rx identifies opportunities for mutually beneficial collaboration

Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, has appointed William G. Kaelin Jr. MD as Chair of its Scientific Advisory Board and Science Advisor to its Board of Directors. Dr. Kaelin is a Howard Hughes Medical Institute Investigator and a professor of medicine at Dana Farber Cancer Institute and Harvard Medical School. He was awarded the

Azitra, Inc . , a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to ATR-12 for the treatment of Netherton syndrome (NS), a chronic genetic skin disease that can be life threatening.

The BIO International Convention is holding its annual event virtually this year amidst the COVID-19 global pandemic. The event brings together capital, scientific and development expertise needed to turn promising innovation into successful medicine.

Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™ , an online configuration and ordering platform for cell culture media. Designed for developers of cell therapies, NB-Lux™ speeds formulation development by providing real time pricing for cGMP grade media in lot sizes from two liters to 2000

Company will focus on process development and improvements for manufacturing Baylor’s Covid-19 vaccine candidates

Fidelis Specialty Pharmacy is proud to announce that it has earned URAC’s prestigious specialty pharmacy accreditation.

Pegfilgrastim is used to fight infection in patients undergoing chemotherapy by stimulating the body’s production of white blood cells Fresenius Kabi’s first U.S. biosimilar candidate

The New Name Captures the Company’s Core Expertise and Long-Term Commitment to Bringing an Expanded Line of Refractive Surgery Products to Surgeons and Patients Worldwide

The Institute for Functional Medicine announced Tracy W. Gaudet, MD, as the closing keynote speaker for IFM’s Annual International Conference 2020: Advancements in Clinical Research and Innovative Practices in Functional Medicine.